Laquinimod data demonstrates neuroprotective properties

If it's on your mind and it has to do with multiple sclerosis in any way, post it here.

Laquinimod data demonstrates neuroprotective properties

Postby MSUK » Fri Oct 15, 2010 11:36 pm

Image

Teva Pharmaceutical Industries Ltd. and Active Biotech announced that data providing further evidence of the neuroprotective properties of laquinimod in animal studies were presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in Gothenburg, Sweden. Laquinimod is an investigational, once-daily oral immunomodulator for the treatment of relapsing remitting multiple sclerosis (RRMS).

These results, generated from several pre-clinical studies evaluating the mechanism of action (MOA) of oral laquinimod, demonstrated that:... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1735
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2123
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Return to General Discussion

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service